Heparin half-life in normal and impaired renal function.
作者信息
Perry P J, Herron G R, King J C
出版信息
Clin Pharmacol Ther. 1974 Sep;16(3):514-9. doi: 10.1002/cpt1974163part1514.
PMID:4413659
Abstract
摘要
相似文献
1
Heparin half-life in normal and impaired renal function.肝素在正常及肾功能受损情况下的半衰期。
Clin Pharmacol Ther. 1974 Sep;16(3):514-9. doi: 10.1002/cpt1974163part1514.
2
Heparin elimination and hemostasis in hemodialysis.血液透析中肝素的清除与止血
Clin Nephrol. 1984 Dec;22(6):303-6.
3
Letter: Heparin half-life in normal and impaired renal function.信函：正常及肾功能受损情况下肝素的半衰期
Clin Pharmacol Ther. 1975 Feb;17(2):249-51. doi: 10.1002/cpt1975172249.
4
[Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].[通过血液凝固分析研究制定慢性血液透析中肝素治疗的个体化剂量方案]
Z Urol Nephrol. 1990 Mar;83(3):133-40.
5
Effect of renal failure and hemodialysis on cephacetrile pharmacokinetics.肾衰竭和血液透析对头孢乙腈药代动力学的影响。
Clin Pharmacol Ther. 1972 Nov-Dec;13(6):887-94. doi: 10.1002/cpt1972136887.
6
Monitoring heparin therapy in hemodialysis. A report on the activated whole blood coagulation time tests.血液透析中肝素治疗的监测。关于活化全血凝固时间试验的报告。
JAMA. 1973 Dec 24;226(13):1529-33. doi: 10.1001/jama.226.13.1529.
7
Flucytosine kinetics in subjects with normal and impaired renal function.肾功能正常和受损受试者的氟胞嘧啶动力学
Clin Pharmacol Ther. 1978 Sep;24(3):333-42. doi: 10.1002/cpt1978243333.
8
[Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].[测定活化全血凝固作为血液透析中肝素剂量的控制参数]
Z Urol Nephrol. 1984 Aug;77(8):465-71.
9
[Study of renal function in renal insufficiency. I. Renal function of the patients under chronic hemodialysis].[肾功能不全患者的肾功能研究。I. 慢性血液透析患者的肾功能]
Hinyokika Kiyo. 1971 Mar;17(3):157-86.
10
Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.使用Cordis Dow 3500中空纤维进行无肝素输注的血液透析。
Proc Clin Dial Transplant Forum. 1980;10:39-42.
引用本文的文献
1
Targeting malaria parasite invasion of red blood cells as an antimalarial strategy.以疟原虫入侵红细胞为靶点的抗疟策略。
FEMS Microbiol Rev. 2019 May 1;43(3):223-238. doi: 10.1093/femsre/fuz005.
2
Pharmacokinetic optimisation of the treatment of deep vein thrombosis.深静脉血栓形成治疗的药代动力学优化
Clin Pharmacokinet. 1997 Feb;32(2):145-72. doi: 10.2165/00003088-199732020-00005.
3
Clinical pharmacokinetics of heparin.肝素的临床药代动力学
Clin Pharmacokinet. 1980 May-Jun;5(3):204-20. doi: 10.2165/00003088-198005030-00002.
4
Heparin pharmacokinetics and pharmacodynamics.肝素的药代动力学和药效学。
Clin Pharmacokinet. 1992 May;22(5):359-74. doi: 10.2165/00003088-199222050-00003.
5
Pharmacokinetic modeling of heparin and its clinical implications.肝素的药代动力学建模及其临床意义。
J Pharmacokinet Biopharm. 1979 Aug;7(4):331-54. doi: 10.1007/BF01062533.
Zotero 插件